For the primary study outcome gestational weight gain 488 GLP-1-exposed pregnancies (people receiving at least one GLP-1 medication between 3 years before and 90 days after pregnancy) were propensity-score matched with 1,344 unexposed pregnancies
This study included 17,604 participants who were overweight or obese and already had cardiovascular disease
There are several expensive brand-named products, such as Ozempic and Wygovy, currently on the market
Subjects received a 16 mg afamelanotide subcutaneous implant or placebo every 60 days (Langendonk et al., 2015)
This ensures adequate nutrient intake, helps maintain muscle mass, and promotes long-term health
The Skinny Shot starts to work within a few weeks of starting treatment